3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Prostatic Neoplasms
8
Glioma
3
Breast Neoplasms
3
Brain Neoplasms
3
Thyroid Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Neoplasms
1
Thyroid Nodule
1
Thrombocythemia, Essential
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Retinoblastoma
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Polycythemia Vera
1
Interventions
venetoclax
124
Azacitidine
96
Cytarabine
71
fludarabine
44
Specimen Handling
38
Cyclophosphamide
38
Daunorubicin
27
Decitabine
26
Biopsy
25
Idarubicin
24
Granulocyte Colony-Stimulating Factor
21
gilteritinib
18
Injections
18
fludarabine phosphate
17
Whole-Body Irradiation
17
Melphalan
16
Busulfan
16
Stem Cell Transplantation
15
Mycophenolic Acid
15
ivosidenib
13
Cladribine
13
decitabine and cedazuridine drug combination
12
Gemtuzumab
12
Tacrolimus
11
CPX-351
11
X-Rays
10
Filgrastim
10
revumenib
9
enasidenib
9
Cyclosporine
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Leukemia, Myeloid, Acute
×
Watchful Waiting
×
Clear all
NCT07613385
2026-05-29
Individualized AML Treatment
City of Hope Medical Center
Recruiting
18 enrolled